CoChat

Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.

Open access

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Most evidence on the association between malaria in pregnancy and adverse pregnancy outcomes focuses on falciparum malaria detected at birth. We assessed the association between the number and timing of falciparum and vivax malaria episodes during pregnancy on small-for-gestational-age (SGA) and preterm birth. METHODS: We analysed observational data collected from antenatal clinics on the Thailand-Myanmar border (1986-2015). We assessed the effects of the total number of malaria episodes in pregnancy on SGA and the effects of malaria in pregnancy on SGA, very preterm birth, and late preterm birth, by the gestational age at malaria detection and treatment using logistic regression models with time-dependent malaria variables (monthly intervals). World Health Organisation definitions of very preterm birth (≥28 and <32 weeks) and late preterm birth (≥32 and <37 weeks) and international SGA standards were used. RESULTS: Of 50,060 pregnant women followed, 8221 (16%) had malaria during their pregnancy. Of the 50,060 newborns, 10,005 (21%) were SGA, 540 (1%) were very preterm, and 4331 (9%) were late preterm. The rates of falciparum and vivax malaria were highest at 6 and 5 weeks' gestation, respectively. The odds of SGA increased linearly by 1.13-fold (95% confidence interval: 1.09, 1.17) and 1.27-fold (1.21, 1.33) per episode of falciparum and vivax malaria, respectively. Falciparum malaria at any gestation period after 12-16 weeks and vivax malaria after 20-24 weeks were associated with SGA (falciparum odds ratio, OR range: 1.15-1.63 [p range: <0.001-0.094]; vivax OR range: 1.12-1.54 [p range: <0.001-0.138]). Falciparum malaria at any gestation period after 24-28 weeks was associated with either very or late preterm birth (OR range: 1.44-2.53; p range: <0.001-0.001). Vivax malaria at 24-28 weeks was associated with very preterm birth (OR: 1.79 [1.11, 2.90]), and vivax malaria at 28-32 weeks was associated with late preterm birth (OR: 1.23 [1.01, 1.50]). Many of these associations held for asymptomatic malaria. CONCLUSIONS: Protection against malaria should be started as early as possible in pregnancy. Malaria control and elimination efforts in the general population can avert the adverse consequences associated with treated asymptomatic malaria in pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-017-0877-6

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study profile. *These women had malaria episodes entered retrospectively, so were not undergoing antenatal screening from ≤10 weeks’ gestation. **These newborns were live born, and are in a ‘grey zone’ between miscarriage and extreme preterm birth (birth at 24–28 weeks’ gestation) [53]
Fig. 1 Study profile. *These women had malaria episodes entered retrospectively, so were not undergoing antenatal screening from ≤10 weeks’ gestation. **These newborns were live born, and are in a ‘grey zone’ between miscarriage and extreme preterm birth (birth at 24–28 weeks’ gestation) [53]CC BY · PubMed Central
Fig. 2 Rates of falciparum and vivax malaria over gestational age in women who started antenatal screening before 10 weeks’ gestation (N = 19,768). Vertical dashed lines are at 14 weeks’ and 28 weeks’ gestation, indicating the end of the first and second trimesters, respectively. Hazard rates were calculated per 1000 pregnancy weeks. For the hazard of initial malaria, women were censored at the gestational age of their first episode, birth, or time last seen. For recurrent malaria, women became at risk at the gestational age of their initial episode and were censored at the gestational age of their first recurrent episode, birth, or time last seen; we did not attempt to account for a post-treatment prophylactic effect because of the strong assumptions that this would require
Fig. 2 Rates of falciparum and vivax malaria over gestational age in women who started antenatal screening before 10 weeks’ gestation (N = 19,768). Vertical dashed lines are at 14 weeks’ and 28 weeks’ gestation, indicating the end of the first and second trimesters, respectively. Hazard rates were calculated per 1000 pregnancy weeks. For the hazard of initial malaria, women were censored at the gestational age of their first episode, birth, or time last seen. For recurrent malaria, women became at risk at the gestational age of their initial episode and were censored at the gestational age of their first recurrent episode, birth, or time last seen; we did not attempt to account for a post-treatment prophylactic effect because of the strong assumptions that this would requireCC BY · PubMed Central
Fig. 3 Descriptive statistics for parasitaemia and symptoms by the gestational age at malaria detection. Orange: falciparum malaria. Blue: vivax malaria. CI confidence interval
Fig. 3 Descriptive statistics for parasitaemia and symptoms by the gestational age at malaria detection. Orange: falciparum malaria. Blue: vivax malaria. CI confidence intervalCC BY · PubMed Central
Fig. 4 The association between the number of malaria episodes in pregnancy and small-for-gestational-age (SGA). Numbers are odds ratios with 95% confidence intervals. See Additional file 4 for a table version of this figure. The associations between the number of episodes and loge(odds) were linear for falciparum malaria (p = 0.819) and vivax malaria (p = 0.118). SGA was missing in 2636 [5%] (no malaria 2078 [5%]; malaria 558 [7%])
Fig. 4 The association between the number of malaria episodes in pregnancy and small-for-gestational-age (SGA). Numbers are odds ratios with 95% confidence intervals. See Additional file 4 for a table version of this figure. The associations between the number of episodes and loge(odds) were linear for falciparum malaria (p = 0.819) and vivax malaria (p = 0.118). SGA was missing in 2636 [5%] (no malaria 2078 [5%]; malaria 558 [7%])CC BY · PubMed Central
Fig. 5 The association between the gestational age at falciparum or vivax malaria detection and treatment and small-for-gestational-age (SGA). See Additional file 5 for a table version of this figure, including differentiation between symptomatic and asymptomatic malaria. The reference group within each time interval is women with no malaria detected within each respective time interval. SGA was missing in 2636 [5%] (no malaria 2078 [5%]; malaria 558 [7%])
Fig. 5 The association between the gestational age at falciparum or vivax malaria detection and treatment and small-for-gestational-age (SGA). See Additional file 5 for a table version of this figure, including differentiation between symptomatic and asymptomatic malaria. The reference group within each time interval is women with no malaria detected within each respective time interval. SGA was missing in 2636 [5%] (no malaria 2078 [5%]; malaria 558 [7%])CC BY · PubMed Central
Fig. 6 The association between the gestational age at falciparum or vivax malaria detection and treatment and preterm birth. The association between malaria at 0–4 and 4–8 weeks’ gestation and very preterm birth was not estimated due to zero events in the malaria groups. See Additional file 6 for a table version of this figure, including differentiation between symptomatic and asymptomatic malaria
Fig. 6 The association between the gestational age at falciparum or vivax malaria detection and treatment and preterm birth. The association between malaria at 0–4 and 4–8 weeks’ gestation and very preterm birth was not estimated due to zero events in the malaria groups. See Additional file 6 for a table version of this figure, including differentiation between symptomatic and asymptomatic malariaCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 111

Metadata

Authors
Moore, K. A., Simpson, J. A., Wiladphaingern, J., Min, A. M., Pimanpanarak, M., Paw, M. K., Raksuansak, J., Pukrittayakamee, S., Fowkes, F. J. I., White, N. J., Nosten, F., & McGready, R.
Affiliations
  • Burnet Institute (AU)
  • The University of Melbourne (AU)
  • Mahidol University (TH)
Corresponding author
Moore, Kerryn A.
Venue
BMC Medicine
Published
2017-06-21
Volume
15
Issue
1
Pages
117-117
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2625355422
Cited by
111
References
59
Citations by year
2026: 6 · 2025: 7 · 2024: 16 · 2023: 8 · 2022: 11 · 2021: 20 · 2020: 23 · 2019: 7 · 2018: 9 · 2017: 4
FWCI
11.04
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Monash University Research Portal (Monash University) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Wellcome Trust (WT-106698)
  • Australian Research Council
  • Australian Commonwealth Government
  • State Government of Victoria
  • National Health and Medical Research Council (1104975)
  • Bill and Melinda Gates Foundation (46589)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
malaria in pregnancy, falciparum malaria, vivax malaria, small for gestational age, preterm birth, very preterm birth, late preterm birth, low malaria transmission, adverse pregnancy outcomes, Thai-Myanmar border, newborn birth weight
MeSH terms
Female, Humans, Infant, Newborn, Infant, Premature, Infant, Small for Gestational Age, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Risk Factors, Odds Ratio, Malaria, Falciparum, Malaria, Vivax

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission. https://app.cochat.ai/papers/10.1186/s12916-017-0877-6
The paper
Moore, K. A., Simpson, J. A., Wiladphaingern, J., Min, A. M., Pimanpanarak, M., Paw, M. K., Raksuansak, J., Pukrittayakamee, S., Fowkes, F. J. I., White, N. J., Nosten, F., & McGready, R. (2017). Influence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission. BMC Medicine. https://doi.org/10.1186/s12916-017-0877-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.